Panels
Patient panel composition
Representative, consented panels across rare and chronic indications. Built from patients who already raised their hand. More voices, more variety, more lived experience in the room.
We don’t go looking for patients. Patients come to us. Curewiki is the Patient Engagement Platform for European clinical research, built with patient organisations, hospitals, and the patients themselves. Sponsors and sites bring their studies. Patients see what fits them, and re-engage when a new opportunity opens.
For Ethics Committee, legal, and DPO reviews: our pre-screening regulatory position.
Patient recruitment is the single biggest cause of trial delays. Sites are overloaded. Eligible patients are hard to reach reliably. Screen failures eat the funnel before randomisation. None of this is an edge case. It is the structural problem clinical operations leaders manage every quarter.
Delays cost sponsors millions in lost revenue every day a launch slips. More than half of trials are terminated for failure to achieve full enrollment. The default playbook is running out of headroom.
Coordinators screen out the majority of leads. That’s screening time, not care time.
Tighter eligibility criteria mean optimistic enrolment curves collapse early.
By the time the funnel is measurable, the budget for fixing it is gone.
Curewiki is patient-initiated, by design. People come to us through their patient organisation, their hospital, or directly. They register their willingness to take part in research, on their own terms. When a study opens, the platform surfaces it to patients who fit, and re-engages them for what’s next. Every study makes the next one faster.
Direct, consented, patient-initiated. Through patient organisations, hospitals, or self-referral.
Sponsors and sites bring protocols. We translate criteria into patient-friendly self-pre-screening.
Patients self-pre-screen against simplified protocol criteria. Obvious mismatches filter themselves out.
That’s how it should be. Sites get a warmer funnel. Sponsors get a fit signal. We stay out of the way.
The database compounds. The same person who self-pre-screened today is the person we re-engage when a fitting study opens next year.
Every research project is different. Curewiki supports the full range of patient engagement work that sits before, around, and after a clinical trial. A patient-facing network and a patient-friendly interface across all of them.
Representative, consented panels across rare and chronic indications. Built from patients who already raised their hand. More voices, more variety, more lived experience in the room.
Stand up structured surveys against opted-in cohorts. Zero-party data, ready for analysis, no intermediaries.
Patients self-pre-screen against simplified protocol criteria. By the time a site sees a referral, the obvious mismatches are already filtered out. By the patient, not by us.
Longitudinal signal from declared health journeys over time. For feasibility, and for everything that comes after.
Patient data comes from one place: declared by the patient themselves, with explicit consent. Full traceability, no intermediaries, no data brokers. The same record reaches sponsor, site, and patient.
Zero-party. Patients declare their own information. No scraping, no purchased lists, no inferred attributes from third-party data brokers.
Full consent. Every record is tied to an explicit, revocable consent. Granular by use case, audit-logged, aligned to GDPR Article 9.
Patient control, always. Patients see what they share, with whom, and when. They can revoke at any moment, for any reason.
No intermediaries. Sponsor and patient see the same record. No data resellers in the middle. Easier internal review for legal, procurement, and patient affairs.
We work with patient organisations, academic hospitals, and research infrastructure that sit inside the platform, not outside it. The network does the heavy lifting, so the engagement layer compounds.
Trusted community channels that bring patients to Curewiki and shape how research is offered to them.
Clinical sites and academic centres that embed Curewiki into their patient pathways.
The integration and research bodies behind the platform’s technical and scientific rigour.
Every pharma buyer asks two questions first: GDPR and security. Both packs are ready on request, alongside our Data Processing Agreement and security white paper. For Ethics Committee questions on pre-screening, our regulatory one-pager covers our position.
Our technical team is based in Belgium and we operate under GDPR, the world’s strictest standard for data privacy and protection.
Risk classification mapped, model documentation maintained, human oversight encoded into the pre-screening flow.
Pre-screening sits outside EC scope by design: patient-initiated, neutral, and never study-specific recruitment. One-pager available for legal and DPO review.
Information security management system implementation underway. Certification expected within the current fiscal year.
Two ways in. Take the case study to circulate internally, or grab the regulatory one-pager for your Ethics Committee and legal review. Both are ready in under a minute.